Variant report

Variant	nsv522563
Chromosome Location	chr5:180051987-180063743
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:17)
CpG islands
(count:732)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:17 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CREB1	chr5:180058933-180059230	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr5:180057425-180057500	H1-hESC	embryonic stem cell:	n/a	chr5:180057427-180057440 chr5:180057482-180057495
3	CTCF	chr5:180060903-180061058	K562	blood:	n/a	n/a
4	CTCF	chr5:180060900-180061050	HepG2	liver:	n/a	n/a
5	CTCF	chr5:180060860-180061010	K562	blood:	n/a	n/a
6	CTCF	chr5:180062384-180062431	GM19239	blood:	n/a	n/a
7	CTCF	chr5:180057580-180057730	GM12865	blood:	n/a	n/a
8	EGR1	chr5:180056713-180056931	K562	blood:	n/a	chr5:180056854-180056868 chr5:180056856-180056867
9	FOSL2	chr5:180063326-180063936	SK-N-SH	brain:	n/a	n/a
10	FOXP2	chr5:180059565-180060038	PFSK-1	brain:	n/a	n/a
11	JUND	chr5:180063364-180063962	SK-N-SH	brain:	n/a	n/a
12	MAX	chr5:180058776-180059089	K562	blood:	n/a	chr5:180058910-180058920 chr5:180058910-180058919 chr5:180058910-180058917
13	MAX	chr5:180053648-180053853	K562	blood:	n/a	n/a
14	NFIC	chr5:180051521-180052077	ECC-1	luminal epithelium:	n/a	chr5:180051814-180051830 chr5:180051813-180051830
15	POLR2A	chr5:180057015-180057092	MCF-7	breast:	n/a	n/a
16	RAD21	chr5:180060908-180061074	K562	blood:	n/a	n/a
17	TCF12	chr5:180063264-180064019	SK-N-SH	brain:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:180052364-180052414	HCT-116	colon:	n/a
2	chr5:180055982-180056032	ECC-1	luminal epithelium:	n/a
3	chr5:180056301-180056351	HCM	heart:	n/a
4	chr5:180057034-180057084	HEEpiC	esophagus:	n/a
5	chr5:180057594-180057644	Jurkat	blood:	n/a
6	chr5:180056040-180056090	Caco-2	colon:	n/a
7	chr5:180057034-180057084	BE2_C	brain:	n/a
8	chr5:180056580-180056630	IMR90	lung:	fetal
9	chr5:180057034-180057084	HCF	heart:	n/a
10	chr5:180057034-180057084	HCM	heart:	n/a
11	chr5:180057303-180057353	IMR90	lung:	fetal
12	chr5:180053982-180054032	RPTEC	kidney:	n/a
13	chr5:180056580-180056630	ECC-1	luminal epithelium:	n/a
14	chr5:180055850-180055900	SKMC	muscle:	n/a
15	chr5:180055982-180056032	HCT-116	colon:	n/a
16	chr5:180055850-180055900	Caco-2	colon:	n/a
17	chr5:180056040-180056090	CMK	blood:	n/a
18	chr5:180057594-180057644	GM12891	blood:	n/a
19	chr5:180055982-180056032	Hepatocyte	liver:	n/a
20	chr5:180056040-180056090	AG09319	gingival:	n/a
21	chr5:180056580-180056630	AG04449	skin:	fetal
22	chr5:180053982-180054032	ovcar-3	ovarian:	n/a
23	chr5:180057594-180057644	SK-N-SH	brain:	n/a
24	chr5:180056040-180056090	H1-hESC	embryonic stem cell:	embryo
25	chr5:180056522-180056572	H1-hESC	embryonic stem cell:	embryo
26	chr5:180056522-180056572	HUVEC	blood vessel:	n/a
27	chr5:180056522-180056572	HCF	heart:	n/a
28	chr5:180056580-180056630	SAEC	small airway:	n/a
29	chr5:180059096-180059146	CMK	blood:	n/a
30	chr5:180059096-180059146	SK-N-MC	brain:	n/a
31	chr5:180059096-180059146	AG04449	skin:	fetal
32	chr5:180055982-180056032	U87	brain:	n/a
33	chr5:180059096-180059146	LNCaP	prostate:	n/a
34	chr5:180056580-180056630	HNPCEpiC	eye:	n/a
35	chr5:180057594-180057644	BJ	skin:	n/a
36	chr5:180052364-180052414	AG04450	lung:	fetal
37	chr5:180055850-180055900	HAEpiC	amniotic membrane:	n/a
38	chr5:180053982-180054032	PANC-1	pancreas:	n/a
39	chr5:180057594-180057644	SK-N-SH_RA	brain:	n/a
40	chr5:180052364-180052414	SKMC	muscle:	n/a
41	chr5:180056301-180056351	HCT-116	colon:	n/a
42	chr5:180056580-180056630	NHDF-neo	bronchial:	n/a
43	chr5:180057034-180057084	SKMC	muscle:	n/a
44	chr5:180059096-180059146	H1-hESC	embryonic stem cell:	embryo
45	chr5:180057303-180057353	A549	lung:	n/a
46	chr5:180057594-180057644	T-47D	breast:	n/a
47	chr5:180055982-180056032	AG09319	gingival:	n/a
48	chr5:180056580-180056630	Jurkat	blood:	n/a
49	chr5:180053982-180054032	LNCaP	prostate:	n/a
50	chr5:180057034-180057084	HAEpiC	amniotic membrane:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:180046012..180054191-chr5:180056996..180060440,8	K562	blood:
2	chr5:180052176..180054289-chr5:180056133..180059074,3	MCF-7	breast:
3	chr5:180030276..180031977-chr5:180049658..180052103,2	MCF-7	breast:
4	chr5:180051235..180053741-chr5:180054610..180058069,3	K562	blood:
5	chr5:180047630..180050366-chr5:180050889..180052970,2	K562	blood:
6	chr5:180048401..180050293-chr5:180059742..180062204,2	MCF-7	breast:
7	chr5:179799196..179802015-chr5:180050331..180053003,2	MCF-7	breast:
8	chr5:180047660..180049691-chr5:180056996..180059691,2	K562	blood:

No data

Variant related genes	Relation type
FLT4	TF binding region
FLT4	CpG island
ENSG00000037280	chromatin interactions

Extended variants
information (count: 779 )
Associated
traits (count: 102 )

Variant overlapped rSNPs/rCNVs (count:779 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs3797104	chr5:180051987-180051988	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs542255093	chr5:180051990-180051991	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs182581421	chr5:180051991-180051992	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs187613427	chr5:180052029-180052030	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs368211664	chr5:180052034-180052035	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs307824	chr5:180052041-180052042	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs307823	chr5:180052108-180052109	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs574626242	chr5:180052164-180052165	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs190874704	chr5:180052187-180052188	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs184069575	chr5:180052229-180052230	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs546093778	chr5:180052245-180052246	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs79524997	chr5:180052247-180052248	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs372829251	chr5:180052248-180052249	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs376997567	chr5:180052250-180052251	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs148882845	chr5:180052259-180052260	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs548136487	chr5:180052283-180052284	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs561735232	chr5:180052292-180052293	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs189047754	chr5:180052298-180052299	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs547460566	chr5:180052312-180052313	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs571057304	chr5:180052343-180052344	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs539620100	chr5:180052347-180052348	Enhancers Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs550455838	chr5:180052410-180052411	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs143526283	chr5:180052477-180052478	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs34551767	chr5:180052500-180052501	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs2892266	chr5:180052503-180052504	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs532365411	chr5:180052521-180052522	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs536149626	chr5:180052549-180052550	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs73812625	chr5:180052580-180052581	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs574464649	chr5:180052643-180052644	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs533909540	chr5:180052666-180052667	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs553553391	chr5:180052668-180052669	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs576989850	chr5:180052683-180052684	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs545633000	chr5:180052694-180052695	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs562809678	chr5:180052732-180052733	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
35	rs112747370	chr5:180052738-180052739	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs552173328	chr5:180052785-180052786	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs111384975	chr5:180052790-180052791	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs541716250	chr5:180052800-180052801	Weak transcription Active TSS Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs561771900	chr5:180052806-180052807	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs3736063	chr5:180052817-180052818	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs372494781	chr5:180052820-180052821	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs201306288	chr5:180052832-180052833	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs375780994	chr5:180052837-180052838	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs564380942	chr5:180052846-180052847	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs200908470	chr5:180052850-180052851	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs370061951	chr5:180052861-180052862	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs143813005	chr5:180052875-180052876	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs202201360	chr5:180052895-180052896	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs570229742	chr5:180052940-180052941	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs3736062	chr5:180052946-180052947	Active TSS Weak transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:102)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Autism	22543975	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:109 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:180040000-180061200	Weak transcription	Gastric	stomach
2	chr5:180046200-180071800	Weak transcription	Liver	Liver
3	chr5:180046400-180072200	Weak transcription	Right Atrium	heart
4	chr5:180046800-180059600	Weak transcription	Pancreas	Pancrea
5	chr5:180048800-180052200	Enhancers	Placenta	Placenta
6	chr5:180050000-180052800	Enhancers	Adipose Nuclei	Adipose
7	chr5:180050000-180052800	Enhancers	Right Ventricle	heart
8	chr5:180050600-180052200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr5:180050800-180052200	Enhancers	Lung	lung
10	chr5:180051000-180056800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
11	chr5:180051600-180052000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
12	chr5:180051600-180052800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
13	chr5:180051600-180053600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
14	chr5:180051600-180054800	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr5:180051800-180053000	Genic enhancers	Spleen	Spleen
16	chr5:180051800-180053600	Weak transcription	Fetal Muscle Leg	muscle
17	chr5:180052200-180052400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
18	chr5:180052200-180052400	Enhancers	Esophagus	oesophagus
19	chr5:180052200-180053000	Bivalent Enhancer	Placenta	Placenta
20	chr5:180052200-180054400	Weak transcription	Lung	lung
21	chr5:180052400-180052800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr5:180052400-180053600	Weak transcription	Esophagus	oesophagus
23	chr5:180052800-180053000	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr5:180052800-180056600	Weak transcription	Adipose Nuclei	Adipose
25	chr5:180052800-180058000	Weak transcription	Right Ventricle	heart
26	chr5:180053000-180053800	Transcr. at gene 5' and 3'	Spleen	Spleen
27	chr5:180053000-180054000	Weak transcription	Placenta	Placenta
28	chr5:180053000-180056800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr5:180053600-180054000	Enhancers	Esophagus	oesophagus
30	chr5:180053600-180055000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
31	chr5:180053800-180058000	Genic enhancers	Spleen	Spleen
32	chr5:180054000-180054200	Weak transcription	Esophagus	oesophagus
33	chr5:180054000-180054600	Enhancers	Placenta	Placenta
34	chr5:180054000-180055000	Enhancers	Fetal Muscle Leg	muscle
35	chr5:180054200-180054400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
36	chr5:180054200-180054600	Enhancers	Esophagus	oesophagus
37	chr5:180054400-180055000	Enhancers	Lung	lung
38	chr5:180054800-180056000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr5:180055000-180055400	Weak transcription	Lung	lung
40	chr5:180055000-180059400	Weak transcription	Fetal Muscle Leg	muscle
41	chr5:180055200-180055400	Bivalent Enhancer	Fetal Stomach	stomach
42	chr5:180055400-180055600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
43	chr5:180055400-180057600	Strong transcription	Lung	lung
44	chr5:180056000-180057200	Bivalent Enhancer	Placenta	Placenta
45	chr5:180056000-180057600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr5:180056600-180056800	Bivalent Enhancer	Fetal Stomach	stomach
47	chr5:180056600-180057600	Strong transcription	Adipose Nuclei	Adipose
48	chr5:180056800-180057000	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
49	chr5:180056800-180057000	Bivalent Enhancer	K562	blood
50	chr5:180056800-180057200	Strong transcription	iPS DF 6.9 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links